NIH-funded research R01 grant

Understanding how Tet enzymes influence blood cell development from endothelial cells

Official title: Role of Tet enzymes in embryonic hematopoiesis

Funded at Albert Einstein College of Medicine · NIH-11042732 · Data updated 2026-11-12

This study is looking at how certain enzymes help turn blood vessel cells into blood cells during early development, which could help us understand blood disorders better and find new ways to treat them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$499,338
NIH project number5R01HL172730-02
Project IDNIH-11042732 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals under 21 years old who may be affected by blood disorders or are interested in the biological mechanisms of blood cell development.

Less likely to help

Patients with established blood disorders that are not related to the mechanisms being studied may not benefit from this research.

What this research studies

This research investigates the role of Tet enzymes in the formation of blood cells from endothelial cells during embryonic development. It aims to uncover the molecular mechanisms that guide the transition of endothelial cells into blood-forming stem and progenitor cells. By utilizing mouse models, the researchers will manipulate the expression of Tet enzymes to observe their effects on blood cell specification. This work could provide insights into how blood disorders may arise and how they can be treated.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating blood disorders by enhancing our understanding of blood cell formation.

How similar studies have gone: While the specific role of Tet enzymes in blood cell development is still being explored, similar research has shown promise in understanding the genetic and epigenetic factors involved in hematopoiesis.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Dawlaty, Meelad — Albert Einstein College of Medicine
  • Study coordinator: Dawlaty, Meelad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.